Fate Therapeutics (FATE) ROE US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
ROE, % | ? | -39.9% | -44.3% | -30.4% | -52.7% | -43.7% | -44.6% | ||
Changes by years, y/y, % | +2pp | -4pp | +14pp | -22pp | +9pp | +1.0% |
Fate Therapeutics. ROE, %
Fate Therapeutics. ROE, changes, pp
Fate Therapeutics (FATE) ROE US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
ROE, % | ? | -43.4% | -43.6% | -38.6% | -41.0% | -44.6% | -44.6% | |
Changes by years, y/y, % | -8pp | -3pp | +15pp | +12pp | -1pp | |||
Changes by quarters, q/q, % | +9pp | 0pp | +5pp | -2pp | -4pp |